Bafna Pharmaceuticals Limited

₹463.55As of Sun 8 Nov 2026, 12:00 UTC
NSE:BAFNAPHHealthcare
Country India
PE (Fwd) •••
TSR 7Y CAGR 71.18%
Div yield —
ROE 12.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.04)
PE TTM 142.9
TSR TTM 222.76%
Mkt cap ₹10.97B
ROIC 4.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹457
(1.31%)
(67.40%)
Hold 6|3|1|10|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
9.08
9.77
10.16
11.10
13.23%
12.63%
17.91%
35.03%
Revenue₹B
1.180
1.194
1.200
1.212
5.43%
5.09%
2.88%
5.15%
Peers (US$114.5M)
Cap (US$)
PE
112.1M
42.58x
111.5M
49.46x
Capital
TTM
5Y
10Y
Leveragex
0.227
0.039
0.027
EBIT/Intx
8.567
0.147
0.130
Own earn%
5.30
58.66
66.14
Sh yield%
32.43
25.86
26.09
Owners
Insiders/Inst%
10.69
33.52
Short interest%
2.54
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
11–18
$1 testx
—
Incr. ROIC%
21